Table 3 Unitary costs (euros)

From: Cost-minimisation analysis of pegylated liposomal doxorubicin hydrochloride versus topotecan in the treatment of patients with recurrent epithelial ovarian cancer in Spain

 

PLD

Topotecan

Cost per mg

19.70

63.91

Antiemetic drugs

NR

22.02

Outpatient visit

115.72

Outpatient consultation

61.32

  1. PLD=pegylated liposomal doxorubicin hydrochloride; NR=not required.
Back to article page